Zeranovia
Commercial- Indications
- Weight loss
Company intelligence / Profile preview
BioAdaptives has launched several commercial products including Xcellara™ Stem Cell Activator and Zeranovia™ weight loss supplement. Clinical evaluations have included randomized, double-blind, placebo-controlled trials showing significant results in weight loss with minimal side effects for Zeranovia™, and increased circulating stem cells in humans and animals for Xcellara™.
5 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAdaptives.